Home › Funds › BRAIDWELL LP › NRIX

BRAIDWELL LP position in NRIX

NURIX THERAPEUTICS INC · Health Care

BRAIDWELL LP reported holding 1,286,769 shares of NRIX (NURIX THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$31.2M, representing 1.23% of its reported portfolio and ranking #32 among its reported holdings. BRAIDWELL LP has disclosed NRIX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)1.29M sh
Reported value held$31.22M
Portfolio Weight1.23%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BRAIDWELL LP's NRIX position evolved

BRAIDWELL LP first disclosed a stake in NRIX in Q4 2025 at 2,183,864 shares (US$41.4M). Across 3 filings, BRAIDWELL LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,286,769 shares valued at US$31.2M — a reduction of -463,997 shares quarter over quarter.. Notable position changes include a 27% trim in Q2 2026 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 2.18M $41.43M New
Q1 2026 1.75M $27.14M Reduce
Q2 2026 1.29M $31.22M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NRIX and 13F data

NRIX (NURIX THERAPEUTICS INC) is a Health Care company. 46 other funds we track also report a position in NRIX — the largest reported positions include Vestal Point Capital, LP (US$195.3M), Deep Track Capital, LP (US$187.7M), Rubric Capital Management LP (US$175.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NRIX

All NRIX fund holders →

FAQ

How long has BRAIDWELL LP held NRIX?

BRAIDWELL LP has disclosed NRIX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is BRAIDWELL LP's current position in NRIX?

As of Q2 2026, BRAIDWELL LP holds 1.29M shares of NRIX (NURIX THERAPEUTICS INC), valued at $31.22M, representing 1.23% of its reported portfolio and ranking #32.

Has BRAIDWELL LP been buying or selling NRIX?

In the latest 13F filing (Q2 2026), BRAIDWELL LP reduced its position in NRIX.

Which other funds hold NRIX?

Other major institutional holders of NRIX include Vestal Point Capital, LP, Deep Track Capital, LP, Rubric Capital Management LP, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.